APA (7th ed.) Citation

Najafipour, M., Najafipour, F., Ostadrahimi, A., Ghavami, M., Razaghi, Z., Tutunchi, H., & Alamdari, N. M. The effects of empagliflozin in patients with type 1 diabetes: Results of a 12-week, double-blind, randomized, placebo-controlled clinical trial. Tabriz University of Medical Sciences.

Chicago Style (17th ed.) Citation

Najafipour, Mostafa, Farzad Najafipour, Alireza Ostadrahimi, Maryam Ghavami, Zohreh Razaghi, Helda Tutunchi, and Naimeh Mesri Alamdari. The Effects of Empagliflozin in Patients with Type 1 Diabetes: Results of a 12-week, Double-blind, Randomized, Placebo-controlled Clinical Trial. Tabriz University of Medical Sciences.

MLA (9th ed.) Citation

Najafipour, Mostafa, et al. The Effects of Empagliflozin in Patients with Type 1 Diabetes: Results of a 12-week, Double-blind, Randomized, Placebo-controlled Clinical Trial. Tabriz University of Medical Sciences.